Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Genasys
GNSS
$78.3M
| $441K | ﹤0.01% |
255,036
+47,400
| +23% | +$87.5K |
|
2902
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
| $440K | ﹤0.01% |
+2,600
| New | +$384K |
|
2903
Insperity
NSP
$2.05B
| $439K | ﹤0.01% |
7,300
-39,800
| -85% | -$2.78M |
|
2904
Braskem
BAK
$924M
| $438K | ﹤0.01% |
133,600
-171,500
| -56% | -$622K |
|
2905
State Street Energy Select Sector SPDR ETF
XLE
$38.5B
| $438K | ﹤0.01% |
10,322
-229,000
| -96% | -$9.54M |
|
2906
Xencor
XNCR
$1.44B
| $437K | ﹤0.01% |
55,600
-96,800
| -64% | -$869K |
|
2907
Good Times Restaurants
GTIM
$14.5M
| $436K | ﹤0.01% |
246,983
-8,546
| -3% | -$15.5K |
|
2908
Polestar Automotive Holding UK
PSNY
$2.11B
| $434K | ﹤0.01% |
+13,520
| New | +$429K |
|
2909
4D Molecular Therapeutics
FDMT
$527M
| $432K | ﹤0.01% |
116,553
+97,000
| +496% | +$341K |
|
2910
Aldeyra Therapeutics
ALDX
$92.3M
| $432K | ﹤0.01% |
112,800
-3,800
| -3% | -$9.82K |
|
2911
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.35B
| $430K | ﹤0.01% |
+4,376
| New | +$397K |
|
2912
St. Joe Company
JOE
$3.64B
| $429K | ﹤0.01% |
9,000
-4,061
| -31% | -$182K |
|
2913
Lexeo Therapeutics
LXEO
$330M
| $427K | ﹤0.01% |
106,200
+85,900
| +423% | +$282K |
|
2914
Nortech Systems
NSYS
$39.4M
| $427K | ﹤0.01% |
47,799
-4,300
| -8% | -$37.4K |
|
2915
DocGo
DCGO
$64M
| $426K | ﹤0.01% |
271,528
-75,507
| -22% | -$141K |
|
2916
Rocky Mountain Chocolate Factory
RMCF
$8.03M
| $426K | ﹤0.01% |
302,147
-8,876
| -3% | -$11.2K |
|
2917
Identive
INVE
$64.8M
| $426K | ﹤0.01% |
130,682
+20,282
| +18% | +$65.1K |
|
2918
CVD Equipment Corp
CVV
$54.8M
| $425K | ﹤0.01% |
142,682
+3,600
| +3% | +$10.6K |
|
2919
Valmont Industries
VMI
$9.43B
| $425K | ﹤0.01% |
1,300
-25,800
| -95% | -$7.91M |
|
2920
Hamilton Beach Brands
HBB
$320M
| $424K | ﹤0.01% |
23,700
-700
| -3% | -$12.4K |
|
2921
NCS Multistage Holdings
NCSM
$124M
| $424K | ﹤0.01% |
14,344
+2,500
| +21% | +$76.5K |
|
2922
AN2 Therapeutics
ANTX
$201M
| $423K | ﹤0.01% |
398,854
+30,146
| +8% | +$35.9K |
|
2923
SB Financial Group
SBFG
$167M
| $423K | ﹤0.01% |
+22,133
| New | +$419K |
|
|
CLPR
2924
Clipper Realty
CLPR
$44.4M
| $422K | ﹤0.01% |
115,057
+18,700
| +19% | +$71.5K |
|
|
AOMR
2925
Angel Oak Mortgage REIT
AOMR
$219M
| $421K | ﹤0.01% |
44,700
-44,500
| -50% | -$404K |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.